The Faculty of Medicine at the University of Bonn has conferred an honorary doctorate on the illustrious researcher Professor Sharon Lewin. The Director of the Peter Doherty Institute for Infection and Immunity and the Cumming Global Centre for Pandemic Therapeutics, Professor Lewin is also a Laureate Professor of Medicine at the University of Melbourne in Australia and collaborates with the University Hospital Bonn. She is being recognized for her exceptional research on the international stage and her groundbreaking work in the field of HIV research in particular.

The scholarship holders from the first two funding rounds of the Federal Ministry of Education and Research (BMBF) and an associate from the ImmunoSensation² Cluster of Excellence came together to exchange ideas and further develop the joint program. The group was joined by a scholarship holder from the Würzburg INTERACT program, one of eight ACS locations across Germany. He is currently spending six months in Bonn and is enriching the exchange with new perspectives.

Depression affects 280 million people worldwide. The mental illness has been proven to lead to changes in eating behavior. Researchers at the University Hospital Bonn (UKB), the University of Bonn and the University Hospital Tübingen have discovered that although patients with depression generally have less appetite, they prefer carbohydrate-rich foods. The results have now been published in the journal "Psychological Medicine".

Scientists from DZNE, University Hospital Bonn (UKB) and the University of Bonn provide new evidence that preventing brain inflammation is a promising approach for the treatment of Alzheimer’s disease. Their findings, based on studies in cell culture, mice and tissue samples from patients, may contribute to the development of more effective therapies. They are published in the scientific journal “Immunity”. 

The event will take place on February 5th, 2025, at 11:00 a.m. in the DZNE lecture hall and last about two hours.

Around 1,500 schoolchildren from six EU countries have been engaged in intensive study of some of the challenges currently facing the world in the company of natural science experts. After completing each module on a different topic, they have been acting as “multipliers,” sharing their knowledge and experiences with their family, friends and classmates. Three schools from Bonn took part.

The “Bone2Gene” project of researchers from the University of Bonn and University Hospital Bonn has been awarded funding worth €1,000,000 as part of the Federal Ministry of Education and Research’s GO-Bio initial program. The money is now enabling the team to progress to the feasibility phase and get its product ready for market launch. This is actually the second grant that the project has secured, the first having been used for the conceptual phase and to test the product’s marketability. “Bone2Gene“ is using artificial intelligence (AI) to make genetic bone conditions known as skeletal dysplasia easier to spot and diagnose.

Recently, the Boehringer Ingelheim Foundation presented two Rise up! Awards 2024 to a scientist from Bonn.